Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Allergy Asthma Proc

Retrieve available abstracts of 130 articles:
HTML format



Single Articles


    November 2022
  1. NIEMINEN O, Palosuo K, Kukkonen K, Makela M, et al
    Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children.
    Allergy Asthma Proc. 2022 Nov 18. doi: 10.2500/aap.2023.44.220079.
    PubMed     Abstract available


  2. SALAZAR PE, Habib N, Pasha MA
    2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis.
    Allergy Asthma Proc. 2022;43:529-532.
    PubMed     Abstract available


  3. GULTUNA S
    Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes.
    Allergy Asthma Proc. 2022;43:e65-e71.
    PubMed     Abstract available


  4. ALVES PB, Pereira HP, Alves MP, Roseta L, et al
    Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population.
    Allergy Asthma Proc. 2022;43:533-542.
    PubMed     Abstract available


  5. BELLANTI JA, Settipane RA
    A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
    Allergy Asthma Proc. 2022;43:471-473.
    PubMed    


  6. GRISCTI SOLER D, Bennici A, Brunetto S, Gangemi S, et al
    Benralizumab in the management of rare primary eosinophilic lung diseases.
    Allergy Asthma Proc. 2022;43:494-500.
    PubMed     Abstract available


  7. GROSS LM, Nelson HS, Khatiwada A, Hoyte FCL, et al
    Curcumin does not significantly affect immediate skin tests.
    Allergy Asthma Proc. 2022;43:543-545.
    PubMed     Abstract available


  8. OZTOP N, Demir S, Unal D, Beyaz S, et al
    Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study.
    Allergy Asthma Proc. 2022;43:519-528.
    PubMed     Abstract available


  9. WALLACE DV
    Treatment options for moderate to severe atopic dermatitis.
    Allergy Asthma Proc. 2022;43:474-493.
    PubMed     Abstract available


  10. FRENKEL LD, Bellanti JA
    Monkeypox viral infection and disease: A challenge for the allergist-immunologist.
    Allergy Asthma Proc. 2022;43:509-518.
    PubMed     Abstract available


  11. NELSON HS
    The return of the mixed respiratory bacterial vaccine.
    Allergy Asthma Proc. 2022;43:501-508.
    PubMed     Abstract available


  12. OZTOP N, Demir S, Toprak ID, Unal D, et al
    Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course.
    Allergy Asthma Proc. 2022;43:546-554.
    PubMed     Abstract available



  13. Abstracts presented at the Eastern Allergy Conference, June 2-5, 2022, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:560-567.
    PubMed    


    September 2022
  14. BOUILLET L, Fain O, Armengol G, Aubineau M, et al
    Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs.
    Allergy Asthma Proc. 2022;43:406-412.
    PubMed     Abstract available


  15. FONACIER L, Banta E, Mawhirt S, Noor I, et al
    Capturing total steroid burden in patients with atopic dermatitis and asthma.
    Allergy Asthma Proc. 2022;43:454-460.
    PubMed     Abstract available


  16. NORRIS M, Ashoor Z, Craig T
    Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus.
    Allergy Asthma Proc. 2022;43:388-396.
    PubMed     Abstract available


  17. KESH S, Singh U, Bernstein JA
    Longitudinal experience with treatment of acquired angioedema using tranexamic acid.
    Allergy Asthma Proc. 2022;43:413-418.
    PubMed     Abstract available


  18. MAMYRBEKOVA S, Iskakova G, Faizullina K, Kuziyeva G, et al
    The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level.
    Allergy Asthma Proc. 2022;43:e58-e64.
    PubMed     Abstract available


  19. BUYUK YAYTOKGIL S, Metbulut AP, Ginis T, Toyran M, et al
    Cat allergy in children and the effect of the COVID-19 pandemic.
    Allergy Asthma Proc. 2022;43:e31-e39.
    PubMed     Abstract available


  20. WANGBERG H, Mortazavi D, Kitsen J, Sanni A, et al
    Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
    Allergy Asthma Proc. 2022;43:446-453.
    PubMed     Abstract available


  21. TAUNK ST, Cardet JC, Ledford DK
    Clinical implications of asthma endotypes and phenotypes.
    Allergy Asthma Proc. 2022;43:375-382.
    PubMed     Abstract available


  22. ZHANG S, Fu Q, Wang S, Jin X, et al
    Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2022;43:e47-e57.
    PubMed     Abstract available


  23. PETERS AT, Bengtson LGS, Chung Y, Emmanuel B, et al
    Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis.
    Allergy Asthma Proc. 2022;43:435-445.
    PubMed     Abstract available


  24. BELLANTI JA
    The long COVID syndrome: A conundrum for the allergist/immunologist.
    Allergy Asthma Proc. 2022;43:368-374.
    PubMed     Abstract available


  25. BELLANTI JA, Settipane RA
    Asthma biomarkers and COVID-19 continue to dominate current medical issues.
    Allergy Asthma Proc. 2022;43:363-367.
    PubMed    


  26. KADDIS T, Joshi S, Anstey KM
    Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
    Allergy Asthma Proc. 2022;43:431-434.
    PubMed     Abstract available


  27. KOIZUMI M, Kuzume K, Ishida Y, Midoro-Horiuti T, et al
    Serum thymus and activation-regulated chemokine (TARC) levels correlate with atopic dermatitis disease severity in patients < 6 months.
    Allergy Asthma Proc. 2022;43:461-467.
    PubMed     Abstract available


  28. RIEDL MA, Neville D, Cloud B, Desai B, et al
    Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives.
    Allergy Asthma Proc. 2022;43:397-405.
    PubMed     Abstract available


    July 2022
  29. CHOI YJ, Seong S, Lee KS, Lee K, et al
    Effects of mechanical washing and drying on the removal of pet allergens.
    Allergy Asthma Proc. 2022 Jul 25. doi: 10.2500/aap.2022.43.220029.
    PubMed     Abstract available


  30. SENGUL EMEKSIZ Z, Yilmaz D, Alan B, Tunc SD, et al
    Clinical utility of serum tryptase levels in pediatric anaphylaxis.
    Allergy Asthma Proc. 2022 Jul 1. doi: 10.2500/aap.2022.43.220042.
    PubMed     Abstract available


  31. PENAGOS M, Durham SR
    Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:292-298.
    PubMed     Abstract available


  32. BELLANTI JA, Settipane RA, DuBuske L
    Essentials of allergen immunotherapy: A primer for the practitioner.
    Allergy Asthma Proc. 2022;43:245-247.
    PubMed     Abstract available


  33. NELSON HS
    Future directions in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:356-362.
    PubMed     Abstract available


  34. GREIWE J, Bernstein JA
    Accelerated/rush allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:344-349.
    PubMed     Abstract available


  35. LARENAS-LINNEMANN D
    Long-term adherence strategies for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:299-304.
    PubMed     Abstract available


  36. WEBER RW
    Assessing cross-reactivity in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:314-321.
    PubMed     Abstract available


  37. TAN TJ, Layhadi JA, Shamji MH
    Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:254-259.
    PubMed     Abstract available


  38. BERNSTEIN DI, Epstein TG
    Safety of subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:267-271.
    PubMed     Abstract available


  39. FINEGOLD I
    A brief history of allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:248-253.
    PubMed     Abstract available


  40. TANKERSLEY M
    Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications.
    Allergy Asthma Proc. 2022;43:322-326.
    PubMed     Abstract available


  41. CALDERON MA, Demoly P
    Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?
    Allergy Asthma Proc. 2022;43:305-309.
    PubMed     Abstract available


  42. GOLDEN DBK
    Venom allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:339-343.
    PubMed     Abstract available


  43. PARASHAR S, Pandya A, Portnoy JM
    Pediatric subcutaneous allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:286-291.
    PubMed     Abstract available


  44. CRETICOS PS
    Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
    Allergy Asthma Proc. 2022;43:260-266.
    PubMed     Abstract available


  45. SUBLETT JL
    United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:333-338.
    PubMed     Abstract available


  46. BLAISS MS
    Pediatric sublingual allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:281-285.
    PubMed     Abstract available


  47. DUBUSKE L
    Efficacy and safety of sublingual allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:272-280.
    PubMed     Abstract available


  48. CAIMMI D, Demoly P
    A review of allergen immunotherapy in asthma.
    Allergy Asthma Proc. 2022;43:310-313.
    PubMed     Abstract available


  49. NELSON HS
    Standardized allergen extracts for allergen immunotherapy.
    Allergy Asthma Proc. 2022;43:327-332.
    PubMed     Abstract available


  50. SETTIPANE RA, Bukstein DA
    Allergen immunotherapy and shared decision-making.
    Allergy Asthma Proc. 2022;43:350-355.
    PubMed     Abstract available


    June 2022
  51. KHAN NS, Rubin E, McKenna B, Sonnenberg F, et al
    Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma.
    Allergy Asthma Proc. 2022 Jun 27. doi: 10.2500/aap.2022.43.220038.
    PubMed     Abstract available


    May 2022
  52. BEYAZ S, Ersoy Y, Bicki E, Ak T, et al
    Psychiatric comorbidity and quality of life in patients with drug hypersensitivity.
    Allergy Asthma Proc. 2022;43:234-242.
    PubMed     Abstract available


  53. BELLANTI JA, Settipane RA
    Eosinophilic esophagitis: from discovery to effective treatment.
    Allergy Asthma Proc. 2022;43:175-177.
    PubMed    


  54. CRAIG T, Feuersenger H, Pragst I, Dang J, et al
    Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
    Allergy Asthma Proc. 2022;43:202-208.
    PubMed     Abstract available


  55. SHER ER, Ross JA, Weine DM, Chandini Arjun A, et al
    Current and emerging therapies for eosinophilic esophagitis.
    Allergy Asthma Proc. 2022;43:178-186.
    PubMed     Abstract available


  56. LANG A, Balmert LC, Weiss M, Pongracic JA, et al
    Real world use of peanut component testing among children in the Chicago metropolitan area.
    Allergy Asthma Proc. 2022;43:226-233.
    PubMed     Abstract available


  57. CAN BOSTAN O, Cakmak ME, Kaya SB, Tuncay G, et al
    The association of timothy grass allergy and cat ownership on cat sensitization.
    Allergy Asthma Proc. 2022;43:220-225.
    PubMed     Abstract available


  58. DENG SJ, Wang J, Liu L, Zhang X, et al
    Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes.
    Allergy Asthma Proc. 2022;43:209-219.
    PubMed     Abstract available


    March 2022

  59. Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii.
    Allergy Asthma Proc. 2022;43:174.
    PubMed    


  60. DIEHL KC, Popadiuk CA, Agbese E, Leslie DL, et al
    Cost assessment of allergy procedures to improve high-value care implementation.
    Allergy Asthma Proc. 2022;43:168-172.
    PubMed     Abstract available


  61. VOELKER DH, Gonzalez-Estrada A, Park MA
    Female sex as a risk factor for penicillin drug allergy in the inpatient setting.
    Allergy Asthma Proc. 2022;43:163-167.
    PubMed     Abstract available


  62. RAMIREZ RM, Jacobs RL, Andrews CP
    Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.
    Allergy Asthma Proc. 2022;43:116-123.
    PubMed     Abstract available


  63. BELLANTI JA, Settipane RA
    Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.
    Allergy Asthma Proc. 2022;43:93-95.
    PubMed    


  64. CHEPY A, Veron M, Gautier S, Farhat MM, et al
    Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema.
    Allergy Asthma Proc. 2022;43:155-162.
    PubMed     Abstract available


  65. BEYAZ S, Demir S, Oztop N, Colakoglu B, et al
    How satisfactory is on-demand icatibant from the patients' perspective in real life?
    Allergy Asthma Proc. 2022;43:148-154.
    PubMed     Abstract available


  66. OZDEN SERTCELIK U, Damadoglu E, Karakaya G, Demir AU, et al
    Impact of socioeconomic factors and house cleaning on asthma control in women.
    Allergy Asthma Proc. 2022;43:140-147.
    PubMed     Abstract available


  67. KIM HS, Yang HJ, Song DJ, Lee YJ, et al
    Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children.
    Allergy Asthma Proc. 2022;43:133-139.
    PubMed     Abstract available


  68. WU G, Hu H, Zhang T, Zhang XD, et al
    Profiles of sensitization and comorbidity in asthma patients with markedly increased serum total IgE (>1000kU/L).
    Allergy Asthma Proc. 2022;43:124-132.
    PubMed     Abstract available


    January 2022
  69. MALLIORI S, Ntzounas A, Lampropoulos P, Koliofoti E, et al
    Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991-2018.
    Allergy Asthma Proc. 2022;43:e17-e24.
    PubMed     Abstract available



  70. Abstracts presented at the Eastern Allergy Conference, June 3-6, 2021, Palm Beach, Florida.
    Allergy Asthma Proc. 2022;43:86-90.
    PubMed    


  71. HARADA K, Baker MG, Agarwal S
    Patient perspectives on penicillin allergy and testing.
    Allergy Asthma Proc. 2022;43:64-69.
    PubMed     Abstract available


  72. BUYUK YAYTOKGIL S, Kulhas Celik I, Karaatmaca B, Ginis T, et al
    Prognosis of food-induced anaphylaxis in children: A single-center real-life study.
    Allergy Asthma Proc. 2022;43:57-63.
    PubMed     Abstract available


  73. SERBES M, Sasihuseyinoglu AS, Ozcan D, Ufuk Altintas D, et al
    Clinical features of anaphylaxis in children.
    Allergy Asthma Proc. 2022;43:50-56.
    PubMed     Abstract available


  74. ALMODALLAL Y, Weaver AL, Joshi AY
    Population-based incidence of food allergies in Olmsted County over 17 years.
    Allergy Asthma Proc. 2022;43:44-49.
    PubMed     Abstract available


  75. AQUINO MR, Bingemann TA, Nanda A, Maples KM, et al
    Delayed allergic skin reactions to vaccines.
    Allergy Asthma Proc. 2022;43:20-29.
    PubMed     Abstract available


  76. YOUSEF E, Korotkaya Y, Simpson AB
    Eosinophilic esophagitis in children: Updates and practical aspects of management for allergists in a non-tertiary care private practice setup.
    Allergy Asthma Proc. 2022;43:5-11.
    PubMed     Abstract available


  77. GRIVCHEVA-PANOVSKA V, Craig TJ, Longhurst H, Bara N, et al
    Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management.
    Allergy Asthma Proc. 2022;43:e1-e10.
    PubMed     Abstract available


  78. PITLICK MM, Joshi AY, Gonzalez-Estrada A, Chiarella SE, et al
    Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Allergy Asthma Proc. 2022;43:40-43.
    PubMed     Abstract available


  79. GALLAGHER MC, Haessler S, Pecoy-Whitcomb E, Bayuk J, et al
    Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Allergy Asthma Proc. 2022;43:37-39.
    PubMed     Abstract available


  80. MAGEN E, Yakov A, Green I, Israel A, et al
    Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.
    Allergy Asthma Proc. 2022;43:30-36.
    PubMed     Abstract available


  81. GANTI P, Suman A, Chaudhary S, Sangha B, et al
    The effect of the socioeconomic status on the measurement of asthma control.
    Allergy Asthma Proc. 2022;43:e11-e16.
    PubMed     Abstract available


  82. MCMURRAY JC, Clair BS, Spriet SW, Min SB, et al
    Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic.
    Allergy Asthma Proc. 2022;43:78-84.
    PubMed     Abstract available


  83. RADOJICIC C
    Guidelines for management of hereditary angioedema: What is new? What is missing?
    Allergy Asthma Proc. 2022;43:12-19.
    PubMed     Abstract available


    November 2021
  84. DEMIRHAN A, Yildirim DD, Arikoglu T, Ozhan AK, et al
    A combined risk modeling strategy for clinical prediction of beta-lactam allergies in children.
    Allergy Asthma Proc. 2021;42:e159-e166.
    PubMed     Abstract available


  85. VEZIR E, Hizal M, Cura Yayla B, Aykac K, et al
    Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
    Allergy Asthma Proc. 2021;42:522-529.
    PubMed     Abstract available


  86. PATEL GB, Chhiba KD, Chen MM, Guo A, et al
    COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Allergy Asthma Proc. 2021;42:515-521.
    PubMed     Abstract available


  87. BURROWS AG, Ellis AK
    Idiopathic anaphylaxis: Diagnosis and management.
    Allergy Asthma Proc. 2021;42:481-488.
    PubMed     Abstract available


  88. VERONEZ CL, Christiansen SC, Smith TD, Riedl MA, et al
    COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.
    Allergy Asthma Proc. 2021;42:506-514.
    PubMed     Abstract available


  89. PAN R, Li Q, Zhu X, Zhou Y, et al
    Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.
    Allergy Asthma Proc. 2021;42:e167-e173.
    PubMed     Abstract available


  90. OLGAC M, Guler SD, Demir S, Unal D, et al
    Paucigranulocytic asthma: Do sputum macrophages matter?
    Allergy Asthma Proc. 2021;42:530-536.
    PubMed     Abstract available


  91. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Safety of ciclesonide in children with asthma: A review of randomized controlled trials.
    Allergy Asthma Proc. 2021;42:471-480.
    PubMed     Abstract available


  92. BLAISS M, Berger W, Chipps B, Hernandez-Trujillo V, et al
    Review of efficacy of ciclesonide for the treatment of asthma in children.
    Allergy Asthma Proc. 2021;42:461-470.
    PubMed     Abstract available


  93. WALLACE DV
    Treatment options for chronic rhinosinusitis with nasal polyps.
    Allergy Asthma Proc. 2021;42:450-460.
    PubMed     Abstract available


    September 2021
  94. SARIOGLU N, Yalcin AD, Sahin F, Soyyigit S, et al
    Does vitamin D deficiency in asthma affect clinical and functional parameters? A Turkish multicenter study.
    Allergy Asthma Proc. 2021;42:e152-e158.
    PubMed     Abstract available


  95. XU H, Gao Y, Xie Y, Liang X, et al
    Bronchial provocation test measured by using the forced oscillation technique to assess airway responsiveness.
    Allergy Asthma Proc. 2021;42:e127-e134.
    PubMed     Abstract available


  96. KOCHIS S, Keet C, Claus LE, Hairston T, et al
    Caregiver perceptions and attitudes associated with oral immunotherapy on social media.
    Allergy Asthma Proc. 2021;42:432-438.
    PubMed     Abstract available


    July 2021
  97. DZIEWA I, Hahn T, Bhardwaj N
    Persistent urticarial rash in a newborn.
    Allergy Asthma Proc. 2021;42:357-361.
    PubMed     Abstract available


  98. MANNING ME, Kashkin JM
    Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies.
    Allergy Asthma Proc. 2021;42:274-282.
    PubMed     Abstract available


  99. ZHU WJ, Liu Y, Wang G, Deng K, et al
    Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study.
    Allergy Asthma Proc. 2021 Jul 14. doi: 10.2500/aap.2021.42.210052.
    PubMed     Abstract available


  100. OCAK M, Akarsu A, Sahiner UM, Soyer O, et al
    Food protein-induced enterocolitis syndrome: Current practices in oral food challenge.
    Allergy Asthma Proc. 2021;42:343-349.
    PubMed     Abstract available


  101. OCAK M, Nain E, Akarsu A, Sahiner UM, et al
    Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
    Allergy Asthma Proc. 2021;42:325-332.
    PubMed     Abstract available


  102. JOHNSON FA, Wirth M, Zhu Z, Hahn J, et al
    Etiology and predictors of cluster attacks of hereditary angioedema that recur despite pharmaceutical treatment.
    Allergy Asthma Proc. 2021;42:317-324.
    PubMed     Abstract available


  103. KWONG KY, Lu YZ, Jauregui E, Scott L, et al
    Persistent airflow obstruction in inner-city children with asthma.
    Allergy Asthma Proc. 2021;42:310-316.
    PubMed     Abstract available


    May 2021
  104. ALZAABI A, Idrees M, Behbehani N, Salah F, et al
    Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia.
    Allergy Asthma Proc. 2021;42:e77-e85.
    PubMed     Abstract available


  105. VAN ZELST CM, de Boer GM, Turk Y, van Huisstede A, et al
    Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study.
    Allergy Asthma Proc. 2021;42:e71-e76.
    PubMed     Abstract available


  106. AJEWOLE O, Lanlokun M, Dimanche S, Craig T, et al
    Short-term prophylaxis for children and adolescents with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:205-213.
    PubMed     Abstract available


  107. ZHANG S, Bernstein JA
    Mast cell activation syndrome: Myths and realities.
    Allergy Asthma Proc. 2021;42:198-204.
    PubMed     Abstract available


  108. RIEDL MA, Craig TJ, Banerji A, Aggarwal K, et al
    Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs.
    Allergy Asthma Proc. 2021;42:S17-S25.
    PubMed     Abstract available


  109. CRAIG TJ, Banerji A, Riedl MA, Best JM, et al
    Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burden.
    Allergy Asthma Proc. 2021;42:S11-S16.
    PubMed     Abstract available


  110. RADOJICIC C, Riedl MA, Craig TJ, Best JM, et al
    Patient perspectives on the treatment burden of injectable medication for hereditary angioedema.
    Allergy Asthma Proc. 2021;42:S4-S10.
    PubMed     Abstract available


  111. BANERJI A, Riedl MA, Craig TJ, Radojicic C, et al
    Insights into the treatment burden of hereditary angioedema in the evolving treatment landscape.
    Allergy Asthma Proc. 2021;42:S1-S3.
    PubMed    


    March 2021
  112. WANG Q, Pittman L, Healey A, Chang J, et al
    Ideal body position for epinephrine autoinjector administration.
    Allergy Asthma Proc. 2021;42:147-152.
    PubMed     Abstract available


  113. CASTALDO AJ, Jervelund C, Corcoran D, Boysen HB, et al
    Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:108-117.
    PubMed     Abstract available



  114. For the patient.
    Allergy Asthma Proc. 2021;42:180.
    PubMed    


  115. GENEROSO AJ, Goldman JA, Wolff AH
    A 62-year-old man with new-onset bullae.
    Allergy Asthma Proc. 2021;42:175-179.
    PubMed     Abstract available


  116. BUYUK YAYTOKGIL S, Guvenir H, Kulhas Celik I, Yilmaz Topal O, et al
    Evaluation of drug patch tests in children.
    Allergy Asthma Proc. 2021;42:167-174.
    PubMed     Abstract available


  117. COHEN JS, Agbim C, Hrdy M, Mottla ME, et al
    Epinephrine autoinjector prescription filling after pediatric emergency department discharge.
    Allergy Asthma Proc. 2021;42:142-146.
    PubMed     Abstract available


  118. SWEIS AM, Locke TB, Ig-Izevbekhai KI, Lin TC, et al
    Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2021;42:136-141.
    PubMed     Abstract available


  119. CAO Y, Liu S, Zhi Y
    Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
    Allergy Asthma Proc. 2021;42:131-135.
    PubMed     Abstract available


  120. ANAGNOSTOU A
    Weighing the benefits and risks of oral immunotherapy in clinical practice.
    Allergy Asthma Proc. 2021;42:118-123.
    PubMed     Abstract available


  121. BELLANTI JA, Settipane RA
    Hereditary angioedema again revisited.
    Allergy Asthma Proc. 2021;42:105-107.
    PubMed    


    January 2021
  122. YORMAZ B, Menevse E, Cetin N, Esin Celik Z, et al
    Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study.
    Allergy Asthma Proc. 2021;42:e30-e39.
    PubMed     Abstract available


  123. TASHKIN DP, Koltun A, Wallace R
    A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness.
    Allergy Asthma Proc. 2021;42:30-35.
    PubMed     Abstract available


  124. JOHNSTON DT, Henry Li H, Craig TJ, Bernstein JA, et al
    Androgen use in hereditary angioedema: A critical appraisal and approaches to transitioning from androgens to other therapies.
    Allergy Asthma Proc. 2021;42:22-29.
    PubMed     Abstract available


  125. OZDEN MAT D, Firat S, Aksu K, Aksu F, et al
    Obstructive sleep apnea is a determinant of asthma control independent of smoking, reflux, and rhinitis.
    Allergy Asthma Proc. 2021;42:e25-e29.
    PubMed     Abstract available


  126. MAGEN E, Waitman DA, Kahan NR
    Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2021;42:e17-e24.
    PubMed     Abstract available


  127. TIOTIU A
    Applying personalized medicine to adult severe asthma.
    Allergy Asthma Proc. 2021;42:e8-e16.
    PubMed     Abstract available


  128. SAVARESE L, Mormile I, Bova M, Petraroli A, et al
    Psychology and hereditary angioedema: A systematic review.
    Allergy Asthma Proc. 2021;42:e1-e7.
    PubMed     Abstract available


  129. AYDIN O, Sozener ZC, Demirel YS, Secil D, et al
    Baker's asthma in bread factory workers.
    Allergy Asthma Proc. 2021;42:72-77.
    PubMed     Abstract available


  130. DUDIAK GJ, Popyack J, Grimm C, Tyson S, et al
    Prior authorization delays biologic initiation and is associated with a risk of asthma exacerbations.
    Allergy Asthma Proc. 2021;42:65-71.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: